Navigation Links
Abbott Launches Fruitified(TM) ZonePerfect(R) All-Natural Nutrition Bars
Date:11/1/2007

New antioxidant-rich recipes provide convenience for on-the-go snacking

COLUMBUS, Ohio, Nov. 1 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced the launch of new Fruitified(TM) ZonePerfect(R) Nutrition Bars, all-natural, antioxidant-packed snacks available in four great-tasting flavors: Apple Cinnamon, Blueberry, Banana Nut and Orange Cranberry. Fruitified ZonePerfect Nutrition Bars are an excellent source of protein and calcium and a good source of fiber(1). Each bar contains 100 percent of the recommended daily value of antioxidant Vitamins C and E.

(Photo: http://www.newscom.com/cgi-bin/prnh/20071101/AQTH062)

According to the American Heart Association, up to 30 percent of Americans are taking some form of antioxidant supplement. Antioxidants, such as Vitamins C and E, may help keep the body balanced and healthy, support the immune system and nourish radiant skin.

"Many of the top antioxidant-abundant foods -- fresh fruits, berries, vegetables, cereals and legumes -- are nutritionally beneficial, but not always convenient for on-the-go snacking," said Rosemary Riley, Ph.D., nutrition scientist for Abbott Nutrition. "Fruitified ZonePerfect Nutrition Bars pack antioxidants and pieces of real fruit into a portable, great-tasting snack."

Fruitified ZonePerfect Nutrition Bars are available nationwide at grocery stores, mass merchandisers, natural foods stores, convenience stores, drug stores and club stores.

About ZonePerfect

ZonePerfect All-Natural Nutrition Bars provide balanced nutrition for busy people who refuse to sacrifice great taste. ZonePerfect Bars are a good source of 19 essential vitamins and minerals that contain 180-210 calories and 14-16 grams of protein per serving. All ZonePerfect Nutrition Bars contain an ideal balance of carbohydrates, protein and fat to keep on-the-go consumers satisfied. They are available in 16 flavors that appeal to taste preferences at any time of day.

For more information about ZonePerfect products, visit http://www.ZonePerfect.com. Access to high-resolution images also is available for the news media at http://www.e-MediaRoom.com/ZonePerfect.

About Abbott Nutrition

Abbott Nutrition (http://www.AbbottNutrition.com) develops and markets a wide range of science-based infant formulas, medical nutritionals, nutrition and energy bars, and related products to support the growth, health and wellness of people of all ages. Abbott Nutrition's internationally recognized brands include the Similac(R) brand of infant formulas; the Gain(R) brand of growing-up milks for older babies and toddlers; the PediaSure(R) brand of nutritionals and snacks for children; and the Ensure(R) brand of adult nutritionals.

Additionally, Abbott Nutrition is a leader in medical foods clinically shown to address the distinct dietary needs of people with serious health conditions or special nutrient requirements, such as the Glucerna(R) brand of nutrition shakes and bars for people with diabetes. Abbott Nutrition also offers specialized nutrition products to meet the unique needs of competitive athletes.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com.

1. See nutrition information for fat content.


'/>"/>
SOURCE Abbott
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Pharmacia may take 51.5 percent Abbott stake
2. Abbott Laboratories to buy Biocompatibles cardiovascular stent business
3. Abbott’s Laboratories R&D Capabilities Questione
4. Abbott Receives CE Mark Certification
5. Abbott to Subsidize Price of HIV Drug
6. Abbott Offers Aluvia to Thailand in Return for Compulsory Licensing Halt
7. Abbotts Humira(r) (Adalimumab) Gets Approval by EU for Crohns Disease Treatment
8. Tony Abbott Confident Of Australias Vote For Performance Not Promise
9. Abbotts RealTime Hepatitis B Viral Load Test Receives CE Marking in Europe
10. AIDS Foundation Lauds Brazil for Negotiating Price Cut on Abbotts Kaletra
11. Glaxo launches pills to help smokers quit in 7-12 weeks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... ... for documenting and diagramming network and data center assets and audio-video devices has ... can request new equipment shapes for free and download shapes and stencils from ...
(Date:3/29/2017)... ... 2017 , ... An inventor from Raynham, Mass., knows the ... conjunction with my braces always rubbed against the inside of my cheeks, causing ... problem." The O.B.S. was the result of his brainstorming. , This patent-pending invention ...
(Date:3/29/2017)... ... March 29, 2017 , ... The assembly of synthetic DNA ... many repetitive steps and often scientists require many different versions of DNA. Therefore, ... results in a lower error rate and cost saving for reagents and consumables. ...
(Date:3/29/2017)... ... 29, 2017 , ... Hamlin Dental Group, multi-location dental office in North ... Dental lasers are safe and effective options, and can be used alone or in ... overall quality of care. , Dr. Hamid Reza of Hamlin Dental Group offers other ...
(Date:3/29/2017)... ... March 29, 2017 , ... Physicians’ Education Resource® (PER®), ... medical education conference for clinicians who manage some of the most difficult-to-treat forms ... , The program will be led by co- chairs Dr. John Marshall, chief ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... March 29, 2017  Experts in the field ... devices like  Soberlink Systems  as a model for ... published in early 2017, concluded that remote blood ... managing patient recovery." The findings of ... Addiction Medicine, detail a range of variables that ...
(Date:3/29/2017)... , March 29, 2017  Glenmark Pharmaceuticals, ... for GSP 301, an investigational fixed-dose combination of ... mcg) administered twice-daily as a nasal spray being ... These results are from a recently completed Phase ... GSP 301 combination therapy versus mometasone, olopatadine or ...
(Date:3/29/2017)... 29, 2017 Research and Markets has announced ... report to their offering. ... The global lifestyle drugs market to grow at a ... report, Global Lifestyle Drugs Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
Breaking Medicine Technology: